As of 2024-07-27, the Relative Valuation of Edwards Lifesciences Corp (EW) is 61.40 USD. This relative valuation is based on P/E multiples. With the latest stock price at 62.37 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is -1.6%.
The range of the Relative Valuation is 57.05 - 76.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.3x - 47.0x | 39.0x |
| Forward P/E multiples | 31.1x - 41.6x | 32.6x |
| Fair Price | 57.05 - 76.48 | 61.40 |
| Upside | -8.5% - 22.6% | -1.6% |
| Date | P/E |
| 2024-07-26 | 38.72 |
| 2024-07-25 | 37.06 |
| 2024-07-24 | 53.98 |
| 2024-07-23 | 54.04 |
| 2024-07-22 | 54.62 |
| 2024-07-19 | 53.70 |
| 2024-07-18 | 53.27 |
| 2024-07-17 | 54.20 |
| 2024-07-16 | 54.46 |
| 2024-07-15 | 55.56 |
| 2024-07-12 | 56.48 |
| 2024-07-11 | 57.64 |
| 2024-07-10 | 58.22 |
| 2024-07-09 | 58.03 |
| 2024-07-08 | 57.01 |
| 2024-07-05 | 57.31 |
| 2024-07-03 | 56.54 |
| 2024-07-02 | 56.63 |
| 2024-07-01 | 56.03 |
| 2024-06-28 | 57.34 |
| 2024-06-27 | 57.94 |
| 2024-06-26 | 56.84 |
| 2024-06-25 | 56.54 |
| 2024-06-24 | 55.98 |
| 2024-06-21 | 56.43 |
| 2024-06-20 | 55.15 |
| 2024-06-18 | 54.95 |
| 2024-06-17 | 53.93 |
| 2024-06-14 | 54.19 |
| 2024-06-13 | 54.42 |
| 2024-06-12 | 54.49 |
| 2024-06-11 | 54.01 |
| 2024-06-10 | 53.45 |
| 2024-06-07 | 54.72 |
| 2024-06-06 | 54.43 |
| 2024-06-05 | 54.05 |
| 2024-06-04 | 54.26 |
| 2024-06-03 | 54.54 |
| 2024-05-31 | 53.94 |
| 2024-05-30 | 54.56 |
| 2024-05-29 | 54.03 |
| 2024-05-28 | 54.03 |
| 2024-05-24 | 54.62 |
| 2024-05-23 | 54.29 |
| 2024-05-22 | 56.00 |
| 2024-05-21 | 56.08 |
| 2024-05-20 | 55.73 |
| 2024-05-17 | 55.34 |
| 2024-05-16 | 55.94 |
| 2024-05-15 | 55.97 |